Tolerance of activated pathogenic CD4+ T cells by transcriptional targeting of dendritic cells

Gene Therapy
B de Andrade PereiraC Fraefel

Abstract

We have recently shown that targeted expression of myelin oligodendrocyte glycoprotein (MOG) to dendritic cells with self-inactivating-lentivirus vectors induces antigen-specific tolerance in naive antigen-specific CD4+ T cells and protects mice from experimental autoimmune encephalomyelitis (EAE). In the present study, we demonstrate that this approach also induces tolerance of activated antigen-specific CD4+ T cells and completely protects mice from passive EAE induction. Tolerance induction did not correlate with the depletion of the preactivated antigen-specific CD4+ T cells. However, upon isolation and in vitro re-stimulation at day 6 after adoptive transfer the MOG-specific CD4+ T cells from the non-tolerized mice produced large amounts of inflammatory cytokines, whereas those from tolerized mice did not. This unresponsiveness correlated with the upregulation of regulatory molecules associated with anergy and regulatory T cells (Tregs). The in vivo depletion of Tregs resulted in EAE susceptibility of the tolerized animals, suggesting that these cells have indeed a role in tolerance induction/maintenance.

References

Mar 23, 2002·Nature Reviews. Immunology·Lucy S K Walker, Abul K Abbas
Oct 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Adam P KohmStephen D Miller
Apr 30, 2003·The Journal of Infectious Diseases·Kenneth L Tyler
Jul 9, 2003·The Journal of Experimental Medicine·Alan D SalamaSamia J Khoury
Mar 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bibiana BielekovaRoland Martin
Mar 17, 2004·Current Opinion in Immunology·Fernando MaciánAnjana Rao
Jul 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yvette E LatchmanArlene H Sharpe
Aug 26, 2006·Nature Clinical Practice. Neurology·Bernhard HemmerHans-Peter Hartung
Jan 11, 2007·Scandinavian Journal of Immunology·A McNeillB T Bäckström
Feb 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Danielle M Turley, Stephen D Miller
Jul 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Adam T HagymasiAdam J Adler
Nov 7, 2007·The Journal of Experimental Medicine·Barbara SerafiniFrancesca Aloisi
Sep 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christiane DreschThomas Brocker
Sep 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel R TonkinKathryn Haskins
Nov 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sif HansdottirGary W Hunninghake
Nov 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·James ChanFrank Alderuccio
Dec 10, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tony J KennaRaymond J Steptoe
Jan 30, 2010·Human Genetics·Rebecca L ZuvichJonathan L Haines
Apr 21, 2010·European Journal of Immunology·Mariam NasreenRaymond J Steptoe
Jun 5, 2010·American Journal of Epidemiology·Farren B S BriggsUNKNOWN International Multiple Sclerosis Genetics Consortium
Apr 15, 2011·Immunological Reviews·Joan M Goverman
Jul 13, 2011·European Journal of Immunology·Christiane DreschCornel Fraefel
Nov 26, 2011·Nature Reviews. Immunology·Lucy S K Walker, David M Sansom
Dec 23, 2011·Annals of Neurology·Nikolaos A PatsopoulosPaul I W de Bakker
Jun 1, 2012·Journal of Neuroinflammation·Moa FranssonAngelica S I Loskog
Jul 12, 2012·Therapeutic Advances in Neurological Disorders·Wanda Castro-BorreroElliot M Frohman
Dec 4, 2012·International Journal of Molecular Sciences·Amedeo AmedeiMario Milco D'Elios
Mar 5, 2013·Journal of Neurology·Sreeram V RamagopalanA Dessa Sadovnick
May 2, 2013·Therapeutic Advances in Neurological Disorders·Klaus Lehmann-HornMartin S Weber
Jun 7, 2013·Science Translational Medicine·Andreas LutterottiRoland Martin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.